JP Patent

JP5645408B2 — 副甲状腺機能亢進症および高カルシウム血症性障害の治療のためのポリカチオン性カルシウムモジュレーターペプチド

Assigned to カイ ファーマシューティカルズ インコーポレーティッド · Expires 2014-12-24 · 11y expired

What this patent protects

Patent listed against Parsabiv.

Drugs covered by this patent

Patent Metadata

Patent number
JP5645408B2
Jurisdiction
JP
Classification
—
Expires
2014-12-24
Drug substance claim
No
Drug product claim
No
Assignee
カイ ファーマシューティカルズ インコーポレーティッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.